Form Type: 4

SEC EDGAR Link
Acccession Number:0000899243-19-021736
Date:2019-08-12
Issuer: GW PHARMACEUTICALS PLC (GWPH)
Original Submission Date:

Reporting Person:

SNYDER DOUGLAS B.
SOVEREIGN HOUSE, VISION PARK, HISTON
CAMBRIDGE, X0 CB24 9BZ

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
ORDINARY SHARES 2019-08-12 S 3,756 d $13.88 79,164 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the sales reported were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on may 14, 2019.
f2 represented by american depositary shares of the issuer ("adss"). each ads represents twelve ordinary shares of the issuer.
f3 the price reported in column 4 is a price per ordinary share converted from price per ads.

Elevate your investments